KEGG   DGROUP: Interleukin inhibitor
Entry
DG02019                     DGroup                                 
Name
Interleukin inhibitor
Type
Target
Member
D03639  
Daclizumab (USAN/INN)
D03058  
Basiliximab (USAN/INN); Basiliximab (genetical recombination) (JAN)  <JP/US>
D02934  
Anakinra (USAN/INN)  <US>
D06635  
Rilonacept (USAN/INN)  <US>
D09214  
Ustekinumab (USAN/INN); Ustekinumab (genetical recombination) (JAN)  <JP/US>
D02596  
Tocilizumab (USAN/INN); Tocilizumab (genetical recombination) (JAN)  <JP/US>
D09315  
Canakinumab (USAN/INN); Canakinumab (genetical recombination) (JAN)  <JP/US>
D09588  
Briakinumab (USAN/INN)
D09967  
Secukinumab (USAN/INN); Secukinumab (genetical recombination) (JAN)  <JP/US>
D09669  
Siltuximab (USAN/INN)  <US>
D10061  
Brodalumab (USAN); Brodalumab (genetical recombination) (JAN)  <JP/US>
D10071  
Ixekizumab (USAN); Ixekizumab (genetical recombination) (JAN)  <JP/US>
D10161  
Sarilumab (USAN); Sarilumab (genetical receombination) (JAN)  <JP/US>
D10080  
Sirukumab (USAN); Sirukumab (genetical recombination) (JAN)
D10438  
Guselkumab (USAN); Guselkumab (genetical recombination) (JAN)  <JP/US>
D10400  
Tildrakizumab (USAN); Tildrakizumab (genetical recombination) (JAN)  <JP/US>
D11052  
Risankizumab (USAN/INN); Risankizumab (genetical recombination) (JAN)  <JP/US>
D11079  
Satralizumab (USAN/INN); Satralizumab (genetical recombination) (JAN)  <JP/US>
D11550  
Bimekizumab (USAN/INN); Bimekizumab (genetical recombination) (JAN)  <JP>
D12066  
Spesolimab (USAN/INN); Spesolimab (genetical recombination) (JAN)  <US>
D09190  
Anti-human thymocyte immunoglobulin, rabbit (JAN)  <JP/US>
D01583  
Pirfenidone (JAN/USAN/INN)  <JP/US>
D08985  
Reslizumab (USAN)  <US>
D04923  
Mepolizumab (USAN/INN); Mepolizumab (genetical recombination) (JAN)  <JP/US>
D09874  
Benralizumab (USAN/INN); Benralizumab (genetical recombination) (JAN)  <JP/US>
D09979  
Tralokinumab (USAN/INN); Tralokinumab (genetical recombination) (JAN)  <US>
D04748  
Lisofylline (USAN/INN)
D06556  
Apilimod mesylate (USAN)
D08857  
Anrukinzumab (USAN)
D09615  
Fezakinumab (USAN/INN)
D09633  
Lebrikizumab (USAN/INN); Lebrikizumab (genetical recombination) (JAN)
D09897  
Enokizumab (USAN/INN)
D09911  
Gevokizumab (USAN/INN)
D10902  
Afasevikumab (USAN/INN)
D10912  
Brazikumab (USAN/INN)
D11080  
Nemolizumab (INN); Nemolizumab (genetical recombination) (JAN)  <JP>
D11123  
Mirikizumab (USAN/INN); Mirikizumab (genetical recombination) (JAN)
D11127  
Tibulizumab (USAN/INN)
D11449  
Etokimab (USAN)
D11759  
Isunakinra (USAN/INN)
D11999  
Itepekimab (USAN/INN)
D12169  
Depemokimab (USAN)
D12278  
Izokibep (USAN/INN)
D12306  
Ordesekimab (USAN)
D12370  
Lutikizumab (INN)
D12375  
Tozorakimab (USAN/INN)
Class
Immunological agent
Remark
ATC code: L04AC
LinkDB

» Japanese version

DBGET integrated database retrieval system